-
Study aim
-
Determination of TAP block effects on postoperative pain control,opioids consumption rate ,nausea and vomiting incidence
-
Design
-
Two arm parallel group randomised trial with blinded postoperative care and outcome assessment
-
Settings and conduct
-
This study will be performed on 60 ASA class I-II patients , the ages of 20--65 years .After obtaining of an informed consent ,they will be allocated to two groups by block random sampling.
-
Participants/Inclusion and exclusion criteria
-
Incclusion criteria:20-65 years patients scheduled elective laparascopic cholecystectomy
Exclution criteria:patient refusal,allergy to local anesthetics,coagulopathy,BMI>35,previous abdominal surgery,pregnancy,addiction
-
Intervention groups
-
TAP GROUP:At the end of the surgery,under ultrasound guidance, 0.2% bupivacaine 20 ml will be injected between rectus abdominis and transverse abdominis at subcostal region.This block will be done bilaterally.
CONTROL GROUP:The transverse abdominal plane block will not be done.
IN both groups,the pain severity by visual analogue scale(VAS),nausea and vomiting incidence,need to mepridine and metocloparmide will be evaluated.
Time frame of assessments :during recovery room stay,at 4h,8h,12h and 24h.All patients will be evaluated before surgery and also will be told them about the VAS,where 0=no pain and 10=worst imaginable pain.In both groups ,all patients and the evaluating person will not awared of being or not being intervention.For nausea :0=none,1=mild,2=moderate,3=sever
-
Main outcome variables
-
severity of pain,opioid consumption ,nausea and vomiting incidence during recovery and up to 24 hours after surgery